Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-125701
Filing Date
2024-11-12
Accepted
2024-11-12 17:33:07
Documents
2
Period of Report
2024-11-08

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1535
2 EX-24.1 ck0001768446-ex24_1.htm EX-24.1 15217
  Complete submission text file 0000950170-24-125701.txt   18315
Mailing Address C/O AMGEN INC ONE AMGEN CENTER DR THOUSAND OAKS CA 91320-1799
Business Address
WILLIAMS DOUGLAS E (Reporting) CIK: 0001184847 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40708 | Film No.: 241450105

Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Issuer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)